Official UK procurement notice
Drug Discovery Advancement Consultancy
Authority: University Of Edinburgh (Education)
What is being bought
Published requirement descriptionThis University of Edinburgh requires highly specialised drug discovery and development consultancy including spinout and commercialisation support.
CPV: Research and development services and related consultancy services
The lotProcurement structure
single lot · no lot value publishedLot #1The Baillie Gifford Pandemic Sciences Hub intend to appoint Future Bio Consultancy to…
The Baillie Gifford Pandemic Sciences Hub intend to appoint Future Bio Consultancy to provide highly specialised strategic advisory services in drug discovery and development including associated spinout and commercialisation support.
The University considers competition to be absent for technical reasons as per Public Contracts (Scotland) Regulations 2015-33 (1) (b) (ii)Technical Reasons:
The consultant identified possesses unique scientific, medical, commercial skills and project-specific knowledge (including therapeutic innovation, AI integration, strategic collaborations, and resource mobilisation) that are all required collectively to enable the University to meet its project requirements.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 28 Oct 2026, 10:22 GMT
- Last source update
- 28 Oct 2026, 10:22 GMT
- Authority reference
NCA31149- FTS notice number
2026/S 000-101898- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-079209Find a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
The Baillie Gifford Pandemic Sciences Hub intend to appoint Future Bio Consultancy to provide highly specialised strategic advisory services in drug discovery and development including associated spinout and commercialisation support.
The University considers competition to be absent for technical reasons as per Public Contracts (Scotland) Regulations 2015-33 (1) (b) (ii)Technical Reasons:
The consultant identified possesses unique scientific, medical, commercial skills and project-specific knowledge (including therapeutic innovation, AI integration, strategic collaborations, and resource mobilisation) that are all required collectively to enable the University to meet its project requirements.
Publisher note: The initial contract period will be 42 months with 1 optional 6 month extension, taking the contract to a maximum of 48 months. NOTE: To register your interest in this notice and obtain any additional information please visit the Public Contracts Scotland Web Site at https://www.publiccontractsscotland.gov.uk/Search/Search_Switch.aspx?ID=846686. (SC Ref:846686)
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Future Bio Consulting LtdSME | £286,440 † | — | Awarded |
Contracts
Contract 101898-2026-NCA31149-1 · Future Bio Consulting LtdSME
- Signed
- 26 Oct 2026
- Value
- £286,440
- Status
- active
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Edinburgh Sherrif CourtReview body
Bidders & participating suppliers
1 commercial party on the notice- Future Bio Consulting LtdAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.